Evidence map›Paper›PMID 42104025›Full record

ArticleEuropean journal of pediatrics2026

Thyroid-metabolic interactions in pediatric epilepsy: insights from central sensitivity indices and peripheral hormone markers.

Valeria Calcaterra, Lucia Labati, Ilaria Anna Maria Scavone, Barbara Scelsa, Pierangelo Veggiotti, Gianvincenzo Zuccotti

Abstract read
In one paragraph

Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Valeria CalcaterraDepartment of Internal Medicine and Therapeutics, University of Pavia, 27100, Pavia, Italy. valeria.calcaterra@unipv.it.
Lucia LabatiPediatric Department, Buzzi Children's Hospital, 20154, Milan, Italy.
Ilaria Anna Maria ScavonePediatric Department, Buzzi Children's Hospital, 20154, Milan, Italy.
Barbara ScelsaPediatric Neurology Unit, V. Buzzi Children's Hospital, 20154, Milan, Italy.
Pierangelo VeggiottiDepartment of Biomedical and Clinical Science, University of Milano, 20157, Milan, Italy.
Gianvincenzo ZuccottiPediatric Department, Buzzi Children's Hospital, 20154, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Childhood epilepsy is often linked to endocrine and metabolic disturbances, partly from prolonged antiseizure treatment. While thyroid dysfunction is known in this population, routine tests may miss subtle changes in hormone sensitivity or peripheral metabolism. This study seeks to thoroughly assess central and peripheral thyroid hormone regulation in pediatric epilepsy and explore its connection to metabolic health. In this cross-sectional study, 152 children and adolescents with epilepsy and 116 age- and sex-matched controls underwent assessment of thyroid function (TSH, FT4, FT3), central thyroid hormone sensitivity indices (TFQI, PTFQI, TSHI, TT3RI, TT4RI), peripheral thyroid hormone metabolism (FT3/FT4 ratio), and metabolic parameters (fasting glucose, insulin, and lipid profile). Stratified and multivariable regression analyses were performed to identify independent associations, and correlation analyses were used to explore thyroid-metabolic relationships. Children with epilepsy had higher fasting insulin and a worse lipid profile than controls. Thyroid function markers (TSH, FT4) and central thyroid sensitivity indices were similar between groups, but FT3 and the FT3/FT4 ratio were elevated, suggesting altered peripheral thyroid metabolism despite preserved central regulation. Multivariable analyses identified BMI z-score as a major independent determinant of metabolic alterations and thyroid hormone sensitivity, while antiepileptic drug exposure and disease duration showed variable and modest associations.

conclusionsPediatric epilepsy is characterized by preserved central thyroid regulation but altered peripheral thyroid hormone metabolism, as reflected by an increased FT3/FT4 ratio. These findings suggest a multifactorial and potentially adaptive endocrine-metabolic remodeling influenced by adiposity and treatment exposure, warranting further investigation in longitudinal studies. WHAT IS KNOWN: • Pediatric epilepsy and antiseizure medications are associated with subtle thyroid alterations and increased metaboli crisk, commonly assessed using TSH and FT4. WHAT IS NEW: • Children with epilepsy show increased FT3 and FT3/FT4 ratio despite preserved central thyroid regulation, suggesting altered peripheral thyroid metabolism. • BMI z-score emerged as a major independent determinant of thyroid sensitivity indices and metabolic impairment.

Indexed as

EpilepsyThyroid GlandThyroid HormonesAdolescentAnticonvulsantsBiomarkersBlood GlucoseBody Mass IndexCase-Control StudiesChildCross-Sectional StudiesFemaleHumansInsulinMaleThyroid Function TestsAnticonvulsantsBiomarkersBlood GlucoseInsulinThyroid HormonesThyrotropinThyroxineEpilepsyFT3/FT4 ratioPediatric populationThyroid hormone metabolismThyroid hormone sensitivity

Identifiers

PMID42104025
PMCPMC13156189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.